ResearchHealthcare › CRVS
Back to Dashboard

CRVS

Corvus Pharmaceuticals, Inc.
Healthcare · Biotechnology
$14.92
Market cap $1.3B

Price Chart

Composite ScoreStrong
76.5Score
FF5
87
MF
PIO
22
QARP
27
CG
46
CV
0
Intrinsic ValueModel estimate

No intrinsic-value estimate for this name yet — the valuation models need fundamentals we don't have.

Factor Profile
FF5PIOQARPMFCVCG

MF has no score for this name — dashed, held at the midpoint.

Where CRVS sits · all 2,442 covered names
CRVS 76.5050100

Ranks 156 of 2,442 — the 93.7th percentile, and 23 of 437 within Healthcare.

Sector Outlook — Healthcare
Pro · locked

Overweight / neutral / underweight call for Healthcare, with conviction, catalysts and risks from our sector deep-research panel.

Upgrade to Pro to unlock sector outlooks →
Analyzing sector peers…

Latest News — CRVS

Options-Implied

The market's own forecast: implied move into earnings, skew, and how today's implied volatility compares with what actually happened the last eight times this name reported.

Create a free account →

The score is free. What changes is the product.

Every number above stays free and needs no account. What we sell is the delta — the day a model changes its reading, the research behind the change, and the book we run on it.

Rating-change alerts

Tell me the day any model changes its reading on CRVS. The score is a snapshot; the change is the signal.

Pre-trade research

The full note behind the number — what the models are reacting to, and what would break the case.

The tracked book

Our own 15-name portfolio, marked daily against the S&P 500 since inception. Every position public.

Peers & sector

CRVS against every name in Healthcare, on every model at once.

Free daily briefing, no card. We’ll tell you when per-ticker rating-change alerts open. Unsubscribe in one click.

Sanctuary Research publishes quantitative investment research and educational content. Nothing here is personalised investment advice, and a model score is not a recommendation to buy or sell. Markets involve risk; do your own due diligence. Scores as of 2026-08-12.